Livecare Corp(LVCE)
USD --+0.00%
Reward44Moderate
Risk43Moderate
📊50%Data
Thin -288% profit margin · Revenue growing 125% YoY
LVCE
+0.0 · +0.00%
USD · PINK
Livecare Corp | Healthcare
Capital Destroyer
Market Cap:381860
ℹ️
Reward Rating
44
Moderate
Bottom 25% (model universe)
50% data coverage
ℹ️
Risk Rating
43
Moderate
Risk Assessment
75% data coverage
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on LVCE to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Livecare Corp?

focuses on addressing the diabetic epidemic and other chronic diseases through state-of-the-art technologies and a human-touch approach.

LVCE · Verdict

Moderate reward · moderate risk

LVCE's standout is balance sheet; profitability and volatility weigh on the picture.

Based on 63% data coverage

LVCE · Verdict

What’s working & what to watch

Strengths 1

  • Balance sheet88/100

    Current ratio 2.14

Watchouts 2

  • Profitability10/100

    -1430% return on equity

  • Volatility35/100

    Below average

Model-based scoring. For information only — not financial advice.

What is Livecare Corp?

focuses on addressing the diabetic epidemic and other chronic diseases through state-of-the-art technologies and a human-touch approach. The company is a real-time health, analytics, service, and monitoring company that provides persons with type II diabetes with solutions. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 381.86K.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (44)

The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap381.86K
P/E RatioN/A
Dividend YieldN/A
52 Week High0.18
52 Week Low0.0012
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding62M
No. of EmployeesN/A
IndustryHealth Information Services
ExchangePINK
Beta1.385
CurrencyUSD